Newland Pharmaceutical Co (SZSE:301277) Other Income (Expense) : ¥11.7 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Newland Pharmaceutical Co Other Income (Expense)?

Newland Pharmaceutical Co's other income expense for the Newland Pharmaceutical Co's pretax income for the three months ended in Mar. 2024 was ¥1.7 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥11.7 Mil.

Newland Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Newland Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newland Pharmaceutical Co Other Income (Expense) Chart

Newland Pharmaceutical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

-17.83

16.96

14.24

-0.60

18.11

Newland Pharmaceutical Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial											8.07	3.99	3.11	2.93	1.69

Newland Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥11.7 Mil.

Newland Pharmaceutical Co (SZSE:301277) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Newland Pharmaceutical Co (SZSE:301277) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newland Pharmaceutical Co Ltd (SZSE:301277) » Definitions » Other Income (Expense)

Traded in Other Exchanges

N/A

Address

East side of the south section of Weiwu Road, Henan Province, Changge, CHN, 461500

Website

http://www.newlandpharma.com

Newland Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chiral pharmaceutical intermediates.

Newland Pharmaceutical Co (SZSE:301277) Headlines

No Headlines